PacBio Enters High-Throughput Carrier Screening Market with Standalone HiFi Sequencing Assay for Challenging Genes
Enhanced PureTarget portfolio replaces the need for multiple tests with single scalable…
Carlsmed, Inc. Selected for Inclusion in Russell 2000 Index
September 22, 2025 09:00 ET | Source: Carlsmed CARLSBAD, Calif., Sept. 22,…
CEA Industries Files Registration Statement for its $500M PIPE. CEO David Namdar Releases Letter to Shareholders
New York, Sept. 21, 2025 (GLOBE NEWSWIRE) -- CEA Industries Inc. (Nasdaq:…
Tracer Launches Initial Exchange Offering on Coinstore: Building a Trusted RWA Ecosystem for Carbon Removal
Singapore, Sept. 20, 2025 (GLOBE NEWSWIRE) -- 15 September 2025 Singapore, Singapore…
New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed
Through Week 56 in the SOLARIS trial, there were no suspected or…
IOC Executive Board approves Olympic medal reallocations for Vancouver 2010 and Sochi 2014
19 September 2025 - The International Olympic Committee (IOC) Executive Board (EB) today took the…
IOC Executive Board approves 13 athletes changes of sporting nationality for the Milano Cortina 2026 Olympic Winter Games
19 September 2025 - Today, during the second day of its meeting…
Net Rowdex: Why Net Rowdex 2025 Emerges as a Next-Gen AI Trading Platform for Investors Read France Report!
New York City, NY, Sept. 20, 2025 (GLOBE NEWSWIRE) -- Introduction to…
MBX Biosciences to Provide Topline Results from its Phase 2 Trial of Potential Once-Weekly Canvuparatide for Hypoparathyroidism (HP) on Monday, September 22
September 19, 2025 16:18 ET | Source: MBX Biosciences, Inc. CARMEL, Ind.,…
Nanjing Jiangbei New Area Issues Global Call for Talents
NANJING, China, Sept. 20, 2025 /PRNewswire/ -- On September 20, Nobel laureates,…
